MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
LLY — Eli Lilly & Co.
NYSEEli Lilly & Co.
$1,143.12
+0.27(+0.02%)
- O
- 1,150.76
- H
- 1,165.73
- L
- 1,139.50
- V
- 1.93M
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 9, 1970
Employees50,000
Stock ExchangeNYSE
Ticker SymbolLLY
Websitehttps://www.lilly.com
Key Financial Statistics
| Market Cap | $1.02T |
| P/E Ratio | N/A |
| Dividend Yield | 0.61% (Quarterly) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $783.85 - $1,292.65 |
| 52-Week Avg Volume | 3.09M |
| VWAP | $1,148.32 |
| Transactions | 96,733 |
| Total Recorded Bars | 13,697 days |